50 million doses in 2020 ... and 1.3 billion doses in 2021

"Pfizer" after announcing the "Corona" vaccine: "A great day for science and humanity"

The two US pharmaceutical companies, Pfizer, and German biotechnology, Biontech, concluded a contract worth 1.95 billion dollars with the United States government to provide 100 million doses of their vaccine against the emerging corona virus (Covid-19), and they also reached supply agreements with the European Union and the Kingdom. United, Canada and Japan.

"Today is a great day for science and humanity," said Pfizer CEO Albert Burla: "We have reached this critical milestone in our vaccine development program at a time the world desperately needs, with infection rates setting new records, hospitals close to fullness, and the fight against economies to reopen."

The CEO of Biontech, Ugur Shaheen, confirmed to «Reuters» that he is optimistic that the vaccination effect of the vaccine will last for a year, although this is not confirmed yet.

The two companies expected that they will manufacture up to 50 million doses of the vaccine in the world in the current year 2020, and up to 1.3 billion doses in 2021.

Today, Pfizer and Biontec announced that their experimental vaccine to prevent the emerging corona virus (Covid-19) is more than 90 percent effective in protecting against the virus, and the two companies said that they had not yet found serious safety concerns and expected This month, obtaining a US permit to use the vaccine in emergency situations.

According to the preliminary results, protection against the virus was achieved among those who had taken the vaccine, seven days after receiving the second dose and 28 days after receiving the first dose.

Follow our latest local and sports news, and the latest political and economic developments via Google news